Triplebar, a biotech company specializing in low-cost animal proteins and cell lines for cultivated meats, has secured a USD 1 million investment from Rabobank, a cooperative Dutch bank.
The funding will be used for accelerating innovation in the biotech and food tech sectors, aiming to address issues like food security and environmental challenges.
Analyst QuickTake: The new cash injection, along with Triplebar’s last funding round , brings the total funds raised by the company to USD 21 million. The company has developed a hyper-throughput screening platform capable of examining 10,000x more biological samples than conventional platforms, allowing for expedited innovation.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.